For patients requiring higher doses, the total daily dose may be increased to a maximum of 400mg, administered as 200mg twice daily
Despite new advancements, there is still an unmet need in migraine treatment, imposing a substantial burden on patients, Simone Braca, MD, a neurology resident and clinical research fellow at the Headache Centre of the University of Naples in Italy, told Medical News Today
Market Restraining Factor Patient Recruitment and Retention Issues Patient recruitment and retention remain critical challenges in the clinical trial industry, significantly hindering the speed and success of drug development
108.2: Mazokopakis EE, Papadakis JA, Papadomanolaki MG, Batistakis AG, Giannakopoulos TG, Protopapadakis EE, Ganotakis ES
Kirsten is also a certified yoga teacher